A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer ...
A new study looking at deaths from cancer, cardiovascular disease and all causes suggests that an inflammatory marker detected in blood tests in middle-aged adults can better predict the risk of death ...
The FDA has approved a blood test to help diagnose Alzheimer's disease, and doctors explain how it works and why it can lead ...
Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...
The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...
BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...
Welltica+ on MSN
New blood test method shows promise for Alzheimer’s research
A new study suggests Alzheimer’s research may soon move beyond hospitals, using nothing more than a few drops of blood ...
A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease. Dr. Sanjay Gupta explains. When Penny Ashford’s father was ...
Share on Pinterest Blood tests may help detect some neurodegenerative diseases in the future. Patricio Nahuelhual/Getty Images Researchers have discovered a blood marker they say can help in ...
A new three-pronged blood test can highlight people with a nearly tripled risk for heart attack, a new study says. The test relies on three blood markers linked to heart disease: lipoprotein a [Lp(a)] ...
Morning Overview on MSN
Scientists spot the blood marker shared by people who hit 90+
Across large population studies, people who live into their nineties and beyond keep showing up with the same quiet signature ...
Please provide your email address to receive an email when new articles are posted on . Biomarker combinations improved detection of pancreatic cancer in a double-blind trial. A phase 3 investigation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results